Pito Chickering
Stock Analyst at Deutsche Bank
(4.45)
# 1,138
Out of 5,044 analysts
367
Total ratings
60%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHC Encompass Health | Reiterated: Buy | $95 → $142 | $123.33 | +15.14% | 16 | Sep 18, 2026 | |
| MDT Medtronic | Rated: Hold | $85 → $92 | $88.48 | +3.98% | 22 | Sep 3, 2026 | |
| MMED MiniMed Group | Rated: Buy | $20 → $25 | $19.71 | +26.84% | 2 | Sep 2, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $36.26 | +2.04% | 4 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $107 → $98 | $89.14 | +9.94% | 18 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $179.25 | +47.84% | 22 | Aug 5, 2026 | |
| MD Pediatrix Medical Group | Rated: Hold | $19 → $25 | $26.64 | -6.16% | 20 | Aug 5, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $60 → $70 | $63.74 | +9.82% | 8 | Aug 3, 2026 | |
| BAX Baxter International | Reiterated: Hold | $20 → $27 | $24.35 | +10.88% | 16 | Jul 31, 2026 | |
| LH Labcorp Holdings | Rated: Hold | $248 → $306 | $312.15 | -1.97% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $60 | $42.73 | +40.42% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $24 | $31.07 | -22.76% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $441 → $476 | $451.09 | +5.52% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $29.25 | +9.40% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $402 → $315 | $277.33 | +13.58% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $16 | $17.30 | -7.51% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $6.06 | +56.77% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $10.54 | +108.73% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $12 | $12.25 | n/a | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $94 | $85.21 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 → $178 | $230.97 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.3382 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $241 | $319.40 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $177.35 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $263.78 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 | $19.78 | n/a | 1 | Apr 19, 2021 |
Encompass Health
Sep 18, 2026
Reiterated: Buy
Price Target: $95 → $142
Current: $123.33
Upside: +15.14%
Medtronic
Sep 3, 2026
Rated: Hold
Price Target: $85 → $92
Current: $88.48
Upside: +3.98%
MiniMed Group
Sep 2, 2026
Rated: Buy
Price Target: $20 → $25
Current: $19.71
Upside: +26.84%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $36.26
Upside: +2.04%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $107 → $98
Current: $89.14
Upside: +9.94%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $179.25
Upside: +47.84%
Pediatrix Medical Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $26.64
Upside: -6.16%
BrightSpring Health Services
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $63.74
Upside: +9.82%
Baxter International
Jul 31, 2026
Reiterated: Hold
Price Target: $20 → $27
Current: $24.35
Upside: +10.88%
Labcorp Holdings
Jul 31, 2026
Rated: Hold
Price Target: $248 → $306
Current: $312.15
Upside: -1.97%
Jul 30, 2026
Reiterated: Buy
Price Target: $108 → $60
Current: $42.73
Upside: +40.42%
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $31.07
Upside: -22.76%
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $451.09
Upside: +5.52%
May 1, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $29.25
Upside: +9.40%
May 1, 2026
Reiterated: Hold
Price Target: $402 → $315
Current: $277.33
Upside: +13.58%
Apr 30, 2026
Reiterated: Hold
Price Target: $18 → $16
Current: $17.30
Upside: -7.51%
Feb 25, 2026
Reiterated: Hold
Price Target: $9.5
Current: $6.06
Upside: +56.77%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $10.54
Upside: +108.73%
Sep 15, 2025
Reiterated: Buy
Price Target: $7 → $12
Current: $12.25
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: $85 → $94
Current: $85.21
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: $136 → $178
Current: $230.97
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.3382
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $205 → $241
Current: $319.40
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $177.35
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $263.78
Upside: n/a
Apr 19, 2021
Reiterated: Hold
Price Target: $62
Current: $19.78
Upside: n/a